Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects

References

• Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–53
   PubMed Web of Science ®Google Scholar
• Garcia M. J., McNamara P. M., Gordon T., Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen‐year follow‐up study. Diabetes 1974; 23: 105–11
   PubMed Web of Science ®Google Scholar
• Juutilainen A., Kortelainen S., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27: 2898–904
   PubMed Web of Science ®Google Scholar
• Grundy S. M., Benjamin I. J., Burke G. L., Chait A., Eckel R. H., Howard B. V., et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134–46
   PubMed Web of Science ®Google Scholar
• Muller W. A. Diabetes mellitus: long time survival. J Insur Med 1998; 30: 17–27
   PubMedGoogle Scholar
• Stamler J., Vaccaro O., Neaton J. D., Wentworth D. Diabetes, other risk factors, and 12‐yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434–44
   PubMed Web of Science ®Google Scholar
• Fazzini P. F., Prati P. L., Rovelli F., Antoniucci D., Menghini F., Seccareccia F., et al. Epidemiology of silent myocardial ischemia in asymptomatic middle‐aged men (the ECCIS Project). Am J Cardiol 1993; 72: 1383–8
   PubMed Web of Science ®Google Scholar
• Nesto R. W. Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care 1999; 22: 1393–5
   PubMed Web of Science ®Google Scholar
• Ledru F., Ducimetiere P., Battaglia S., Courbon D., Beverelli F., Guize L., et al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol 2001; 37: 1543–50
   PubMed Web of Science ®Google Scholar
• Taubert G., Winkelmann B. R., Schleiffer T., Marz W., Winkler R., Gok R., et al. Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 2003; 145: 285–91
   PubMed Web of Science ®Google Scholar
• Waller B. F., Palumbo P. J., Lie J. T., Roberts W. C. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980; 69: 498–506
   PubMed Web of Science ®Google Scholar
• Vlietstra R. E., Kronmal R. A., Frye R. L., Seth A. K., Tristani F. E., Killip T., III. Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study. Arteriosclerosis 1982; 2: 208–15
   PubMedGoogle Scholar
• Pajunen P., Nieminen M. S., Taskinen M. R., Syvanne M. Quantitative comparison of angiographic characteristics of coronary artery disease in patients with noninsulin‐dependent diabetes mellitus compared with matched nondiabetic control subjects. Am J Cardiol 1997; 80: 550–6
   PubMed Web of Science ®Google Scholar
• Gandelman G., Bodenheimer M. M. Screening coronary arteriography in the primary prevention of coronary artery disease. Heart Dis 2003; 5: 335–44
   PubMedGoogle Scholar
• Faglia E., Manuela M., Antonella Q., Michela G., Vincenzo C., Maurizio C., et al. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open‐label randomized pilot study. Am Heart J 2005; 149: e1–6
   PubMed Web of Science ®Google Scholar
• Turner R. C., Millns H., Neil H. A., Stratton I. M., Manley S. E., Matthews D. R., et al. Risk factors for coronary artery disease in non‐insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br Med J 1998; 316: 823–8
   PubMed Web of Science ®Google Scholar
• Alberti K. G. M., Zimmet P., Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059–62
   PubMed Web of Science ®Google Scholar
• World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. World Health Organization, Geneva 1999
   Google Scholar
• Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 2735–52
   PubMed Web of Science ®Google Scholar
• Balkau B., Charles M. A., Drivsholm T., Borch‐Johnsen K., Wareham N., Yudkin J. S., et al. European Group For The Study Of Insulin Resistance (EGIR): frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364–76
   PubMed Web of Science ®Google Scholar
• Einhorn D., Reaven G. M., Cobin R. H., Ford E., Ganda O. P., Handelsman Y., et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237–52
   PubMedGoogle Scholar
• Johansen O. E., Birkeland K. I., Brustad E., Lindahl A. K., Midha R., Ueland T., et al. Undiagnosed dysglycaemia and inflammation in cardiovascular disease. Eur J Clin Invest 2006; 36: 544–51
   PubMed Web of Science ®Google Scholar
• Pickup J. C., Mattock M. B., Chusney G. D., Burt D. NIDDM as a disease of the innate immune system: association of acute‐phase reactants and interleukin‐6 with metabolic syndrome X. Diabetologia 1997; 40: 1286–92
   PubMed Web of Science ®Google Scholar
• Birkeland K. I., Claudi T., Hansteen V., Hanssen K. F., Hjermann I., Jenssen T., et al. Prevention of cardiovascular disease in type 2 diabetes. Tidsskr Nor Laegeforen 2000; 120: 2554–9
   PubMedGoogle Scholar
• The Norwegian Medicines Agency. Publication 2001;03:1–92. http://www.legemiddelverket.no/upload/20014/publikasjon3‐2001.pdf
   Google Scholar
• Campeau L. Grading of angina pectoris. Circulation 1976; 54: 522–3
   PubMed Web of Science ®Google Scholar
• Koistinen M. J. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. Br Med J 1990; 301: 92–5
   PubMed Web of Science ®Google Scholar
• Janand‐Delenne B., Savin B., Habib G., Bory M., Vague P., Lassmann‐Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999; 22: 1396–400
   PubMed Web of Science ®Google Scholar
• Bacci S., Villella M., Villella A., Langialonga T., Grilli M., Rauseo A., et al. Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 2002; 147: 649–54
   PubMed Web of Science ®Google Scholar
• Thurnheer R., Muntwyler J., Stammberger U., Bloch K. E., Zollinger A., Weder W., et al. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest 1997; 112: 122–8
   PubMed Web of Science ®Google Scholar
• Enbergs A., Burger R., Reinecke H., Borggrefe M., Breithardt G., Kerber S. Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J 2000; 21: 45–52
   PubMed Web of Science ®Google Scholar
• Koistinen M. J., Huikuri H. V., Korhonen U. R., Linnaluoto M. K., Kuusi T., Takkunen J. T., et al. Asymptomatic coronary artery disease in diabetes: relation to common risk factors, lipoproteins, apoproteins and apo E polymorphism. Acta Diabetol 1994; 31: 210–4
   PubMed Web of Science ®Google Scholar
• Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005; 48: 1684–99
   PubMed Web of Science ®Google Scholar
• Gale E. A. The myth of the metabolic syndrome. Diabetologia 2005; 48: 1679–83
   PubMed Web of Science ®Google Scholar
• Antoniades C., Tousoulis D., Tountas C., Tentolouris C., Toutouza M., Vasiliadou C., et al. Vascular endothelium and inflammatory process, in patients with combined type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C. Diabet Med 2004; 21: 552–8
   PubMed Web of Science ®Google Scholar
• Panichi V., Maggiore U., Taccola D., Migliori M., Rizza G. M., Consani C., et al. Interleukin‐6 is a stronger predictor of total and cardiovascular mortality than C‐reactive protein in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1154–60
   PubMed Web of Science ®Google Scholar
• Tzoulaki I., Murray G. D., Lee A. J., Rumley A., Lowe G. D., Fowkes F. G. C‐reactive protein, interleukin‐6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005; 112: 976–83
   PubMed Web of Science ®Google Scholar
• Porreca E., Di Febbo C., Baccante G., Di Nisio M., Cuccurullo F. Increased transforming growth factor‐beta(1) circulating levels and production in human monocytes after 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme a reductase inhibition with pravastatin. J Am Coll Cardiol 2002; 39: 1752–7
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. The IDF Global Guideline for Type 2 Diabetes. Available at http://www.idf.org (last accessed August 2006).
   Google Scholar
• Scognamiglio R., Negut C., Ramondo A., Tiengo A., Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 2006; 47: 65–71
   PubMed Web of Science ®Google Scholar
• Wyman R. M., Safian R. D., Portway V., Skillman J. J., McKay R. G., Baim D. S. Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol 1988; 12: 1400–6
   PubMed Web of Science ®Google Scholar